Literature DB >> 18779962

FDG-PET in gynaecological cancers: recent observations.

Giovanni Lucignani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18779962     DOI： 10.1007/s00259-008-0929-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  21 in total

1.  Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer.

Authors:  R Suzuki; E Miyagi; N Takahashi; A Sukegawa; A Suzuki; I Koike; K Sugiura; N Okamoto; T Inoue; F Hirahara
Journal:  Int J Gynecol Cancer       Date:  2007-03-02       Impact factor: 3.437

Review 2.  The disparity of cervical cancer in diverse populations.

Authors:  Levi S Downs; Jennifer S Smith; Isabel Scarinci; Lisa Flowers; Groesbeck Parham
Journal:  Gynecol Oncol       Date:  2008-05       Impact factor: 5.482

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer.

Authors:  Jeong-Yeol Park; Eyu Nyong Kim; Dae-Yeon Kim; Dae-Shik Suh; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  Gynecol Oncol       Date:  2008-01-16       Impact factor: 5.482

Review 5.  Endometrial cancer.

Authors:  Joel I Sorosky
Journal:  Obstet Gynecol       Date:  2008-02       Impact factor: 7.661

6.  Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence.

Authors:  Michael Soussan; Myriam Wartski; Pascal Cherel; Emmanuelle Fourme; Alain Goupil; Elise Le Stanc; Nasrine Callet; Jérôme Alexandre; Alain-Paul Pecking; Jean-Louis Alberini
Journal:  Gynecol Oncol       Date:  2007-10-24       Impact factor: 5.482

7.  Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.

Authors:  Mathias Boughanim; Sophie Leboulleux; Annie Rey; Chi Tuan Pham; Yaelle Zafrani; Pierre Duvillard; Jean Lumbroso; Christine Haie-Meder; Martin Schlumberger; Philippe Morice
Journal:  J Clin Oncol       Date:  2008-05-20       Impact factor: 44.544

8.  Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Ichio Fukasawa; Noriyuki Inaba; Narufumi Suganuma; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

9.  Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.

Authors:  Chan Kyo Kim; Byung Kwan Park; Joon Young Choi; Byoung-Gie Kim; Heon Han
Journal:  J Comput Assist Tomogr       Date:  2007 Nov-Dec       Impact factor: 1.826

10.  Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.

Authors:  Tzu-Chen Yen; Lai-Chu See; Chyong-Huey Lai; Chien-Sheng Tsai; Angel Chao; Swei Hsueh; Ji-Hong Hong; Ting-Chang Chang; Koon-Kwan Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-23       Impact factor: 10.057
View more
  2 in total

1.  Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?

Authors:  Alexandra Nikaki; Athanasios Alexopoulos; Fani Vlachou; Vasiliki Filippi; Ioannis Andreou; Vasiliki Rapti; Konstantinos Gogos; Konstantinos Dalianis; Roxani Efthymiadou; Vassilios Prassopoulos
Journal:  Mol Imaging Radionucl Ther       Date:  2016-06-05

2.  Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET.

Authors:  Yoshio Yoshida; Tetsuji Kurokawa; Tetuya Tsujikawa; Hidehiko Okazawa; Fumikazu Kotsuji
Journal:  J Ovarian Res       Date:  2009-06-16       Impact factor: 4.234
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.